Classifying the evolutionary and ecological features of neoplasms

Carlo C. Maley, Athena Aktipis, Trevor A. Graham, Andrea Sottoriva, Amy M. Boddy, Michalina Janiszewska, Ariosto S. Silva, Marco Gerlinger, Yinyin Yuan, Kenneth Pienta, Karen S. Anderson, Robert Gatenby, Charles Swanton, David Posada, Chung I. Wu, Joshua D. Schiffman, E. Shelley Hwang, Kornelia Polyak, Alexander R.A. Anderson, Joel S. BrownMel Greaves, Darryl Shibata

Research output: Contribution to journalReview article

Abstract

Neoplasms change over time through a process of cell-level evolution, driven by genetic and epigenetic alterations. However, the ecology of the microenvironment of a neoplastic cell determines which changes provide adaptive benefits. There is widespread recognition of the importance of these evolutionary and ecological processes in cancer, but to date, no system has been proposed for drawing clinically relevant distinctions between how different tumours are evolving. On the basis of a consensus conference of experts in the fields of cancer evolution and cancer ecology, we propose a framework for classifying tumours that is based on four relevant components. These are the diversity of neoplastic cells (intratumoural heterogeneity) and changes over time in that diversity, which make up an evolutionary index (Evo-index), as well as the hazards to neoplastic cell survival and the resources available to neoplastic cells, which make up an ecological index (Eco-index). We review evidence demonstrating the importance of each of these factors and describe multiple methods that can be used to measure them. Development of this classification system holds promise for enabling clinicians to personalize optimal interventions based on the evolvability of the patient's tumour. The Evo-A nd Eco-indices provide a common lexicon for communicating about how neoplasms change in response to interventions, with potential implications for clinical trials, personalized medicine and basic cancer research.

Original languageEnglish (US)
Pages (from-to)605-619
Number of pages15
JournalNature Reviews Cancer
Volume17
Issue number10
DOIs
StatePublished - Oct 1 2017

Fingerprint

Neoplasms
Ecology
Precision Medicine
Molecular Evolution
Epigenomics
Cell Survival
Clinical Trials
Research

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Maley, C. C., Aktipis, A., Graham, T. A., Sottoriva, A., Boddy, A. M., Janiszewska, M., ... Shibata, D. (2017). Classifying the evolutionary and ecological features of neoplasms. Nature Reviews Cancer, 17(10), 605-619. https://doi.org/10.1038/nrc.2017.69

Classifying the evolutionary and ecological features of neoplasms. / Maley, Carlo C.; Aktipis, Athena; Graham, Trevor A.; Sottoriva, Andrea; Boddy, Amy M.; Janiszewska, Michalina; Silva, Ariosto S.; Gerlinger, Marco; Yuan, Yinyin; Pienta, Kenneth; Anderson, Karen S.; Gatenby, Robert; Swanton, Charles; Posada, David; Wu, Chung I.; Schiffman, Joshua D.; Hwang, E. Shelley; Polyak, Kornelia; Anderson, Alexander R.A.; Brown, Joel S.; Greaves, Mel; Shibata, Darryl.

In: Nature Reviews Cancer, Vol. 17, No. 10, 01.10.2017, p. 605-619.

Research output: Contribution to journalReview article

Maley, CC, Aktipis, A, Graham, TA, Sottoriva, A, Boddy, AM, Janiszewska, M, Silva, AS, Gerlinger, M, Yuan, Y, Pienta, K, Anderson, KS, Gatenby, R, Swanton, C, Posada, D, Wu, CI, Schiffman, JD, Hwang, ES, Polyak, K, Anderson, ARA, Brown, JS, Greaves, M & Shibata, D 2017, 'Classifying the evolutionary and ecological features of neoplasms', Nature Reviews Cancer, vol. 17, no. 10, pp. 605-619. https://doi.org/10.1038/nrc.2017.69
Maley CC, Aktipis A, Graham TA, Sottoriva A, Boddy AM, Janiszewska M et al. Classifying the evolutionary and ecological features of neoplasms. Nature Reviews Cancer. 2017 Oct 1;17(10):605-619. https://doi.org/10.1038/nrc.2017.69
Maley, Carlo C. ; Aktipis, Athena ; Graham, Trevor A. ; Sottoriva, Andrea ; Boddy, Amy M. ; Janiszewska, Michalina ; Silva, Ariosto S. ; Gerlinger, Marco ; Yuan, Yinyin ; Pienta, Kenneth ; Anderson, Karen S. ; Gatenby, Robert ; Swanton, Charles ; Posada, David ; Wu, Chung I. ; Schiffman, Joshua D. ; Hwang, E. Shelley ; Polyak, Kornelia ; Anderson, Alexander R.A. ; Brown, Joel S. ; Greaves, Mel ; Shibata, Darryl. / Classifying the evolutionary and ecological features of neoplasms. In: Nature Reviews Cancer. 2017 ; Vol. 17, No. 10. pp. 605-619.
@article{203a2353254c40848377571a111fc906,
title = "Classifying the evolutionary and ecological features of neoplasms",
abstract = "Neoplasms change over time through a process of cell-level evolution, driven by genetic and epigenetic alterations. However, the ecology of the microenvironment of a neoplastic cell determines which changes provide adaptive benefits. There is widespread recognition of the importance of these evolutionary and ecological processes in cancer, but to date, no system has been proposed for drawing clinically relevant distinctions between how different tumours are evolving. On the basis of a consensus conference of experts in the fields of cancer evolution and cancer ecology, we propose a framework for classifying tumours that is based on four relevant components. These are the diversity of neoplastic cells (intratumoural heterogeneity) and changes over time in that diversity, which make up an evolutionary index (Evo-index), as well as the hazards to neoplastic cell survival and the resources available to neoplastic cells, which make up an ecological index (Eco-index). We review evidence demonstrating the importance of each of these factors and describe multiple methods that can be used to measure them. Development of this classification system holds promise for enabling clinicians to personalize optimal interventions based on the evolvability of the patient's tumour. The Evo-A nd Eco-indices provide a common lexicon for communicating about how neoplasms change in response to interventions, with potential implications for clinical trials, personalized medicine and basic cancer research.",
author = "Maley, {Carlo C.} and Athena Aktipis and Graham, {Trevor A.} and Andrea Sottoriva and Boddy, {Amy M.} and Michalina Janiszewska and Silva, {Ariosto S.} and Marco Gerlinger and Yinyin Yuan and Kenneth Pienta and Anderson, {Karen S.} and Robert Gatenby and Charles Swanton and David Posada and Wu, {Chung I.} and Schiffman, {Joshua D.} and Hwang, {E. Shelley} and Kornelia Polyak and Anderson, {Alexander R.A.} and Brown, {Joel S.} and Mel Greaves and Darryl Shibata",
year = "2017",
month = "10",
day = "1",
doi = "10.1038/nrc.2017.69",
language = "English (US)",
volume = "17",
pages = "605--619",
journal = "Nature Reviews Cancer",
issn = "1474-175X",
publisher = "Nature Publishing Group",
number = "10",

}

TY - JOUR

T1 - Classifying the evolutionary and ecological features of neoplasms

AU - Maley, Carlo C.

AU - Aktipis, Athena

AU - Graham, Trevor A.

AU - Sottoriva, Andrea

AU - Boddy, Amy M.

AU - Janiszewska, Michalina

AU - Silva, Ariosto S.

AU - Gerlinger, Marco

AU - Yuan, Yinyin

AU - Pienta, Kenneth

AU - Anderson, Karen S.

AU - Gatenby, Robert

AU - Swanton, Charles

AU - Posada, David

AU - Wu, Chung I.

AU - Schiffman, Joshua D.

AU - Hwang, E. Shelley

AU - Polyak, Kornelia

AU - Anderson, Alexander R.A.

AU - Brown, Joel S.

AU - Greaves, Mel

AU - Shibata, Darryl

PY - 2017/10/1

Y1 - 2017/10/1

N2 - Neoplasms change over time through a process of cell-level evolution, driven by genetic and epigenetic alterations. However, the ecology of the microenvironment of a neoplastic cell determines which changes provide adaptive benefits. There is widespread recognition of the importance of these evolutionary and ecological processes in cancer, but to date, no system has been proposed for drawing clinically relevant distinctions between how different tumours are evolving. On the basis of a consensus conference of experts in the fields of cancer evolution and cancer ecology, we propose a framework for classifying tumours that is based on four relevant components. These are the diversity of neoplastic cells (intratumoural heterogeneity) and changes over time in that diversity, which make up an evolutionary index (Evo-index), as well as the hazards to neoplastic cell survival and the resources available to neoplastic cells, which make up an ecological index (Eco-index). We review evidence demonstrating the importance of each of these factors and describe multiple methods that can be used to measure them. Development of this classification system holds promise for enabling clinicians to personalize optimal interventions based on the evolvability of the patient's tumour. The Evo-A nd Eco-indices provide a common lexicon for communicating about how neoplasms change in response to interventions, with potential implications for clinical trials, personalized medicine and basic cancer research.

AB - Neoplasms change over time through a process of cell-level evolution, driven by genetic and epigenetic alterations. However, the ecology of the microenvironment of a neoplastic cell determines which changes provide adaptive benefits. There is widespread recognition of the importance of these evolutionary and ecological processes in cancer, but to date, no system has been proposed for drawing clinically relevant distinctions between how different tumours are evolving. On the basis of a consensus conference of experts in the fields of cancer evolution and cancer ecology, we propose a framework for classifying tumours that is based on four relevant components. These are the diversity of neoplastic cells (intratumoural heterogeneity) and changes over time in that diversity, which make up an evolutionary index (Evo-index), as well as the hazards to neoplastic cell survival and the resources available to neoplastic cells, which make up an ecological index (Eco-index). We review evidence demonstrating the importance of each of these factors and describe multiple methods that can be used to measure them. Development of this classification system holds promise for enabling clinicians to personalize optimal interventions based on the evolvability of the patient's tumour. The Evo-A nd Eco-indices provide a common lexicon for communicating about how neoplasms change in response to interventions, with potential implications for clinical trials, personalized medicine and basic cancer research.

UR - http://www.scopus.com/inward/record.url?scp=85030169780&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85030169780&partnerID=8YFLogxK

U2 - 10.1038/nrc.2017.69

DO - 10.1038/nrc.2017.69

M3 - Review article

C2 - 28912577

AN - SCOPUS:85030169780

VL - 17

SP - 605

EP - 619

JO - Nature Reviews Cancer

JF - Nature Reviews Cancer

SN - 1474-175X

IS - 10

ER -